BioSpace News Archive

Clinical trials are the backbone of scientific progress; every new drug, device, or medical procedure must be investigated to ensure their safety and efficacy. Standard clinical trials – like randomized controlled trials (RCT) – often include large groups of people and are not tailored for personalized care.

Boston Imaging, the United States headquarters of Samsung digital radiography and ultrasound business, introduces the V7; a cutting-edge ultrasound system that provides a wide range of clinical applications that enhance both the patient and user experience.

Vyriad, Inc., a biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announces the appointment of Scott Beck, MBA as Chief Operating Officer.

Surgalign Holdings, Inc. announced two upcoming industry events it will be participating in and showcasing many of its latest spine and technology innovations.

Cofactor Genomics, a Predictive Immune Modeling company, today presented initial results from the PREDAPT

argenx announced that during the extraordinary general meeting of shareholders held at 6:30pm CET, Mrs. Camilla Sylvest was appointed as non-executive director to its Board of Directors.

InMed Pharmaceuticals Inc., a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, announces an update on its research/development and commercial activities.

Today, the U.S. Food and Drug Administration issued a safety communication informing patients and providers about reports of squamous cell carcinoma (SCC) and various lymphomas located in the capsule or scar tissue around breast implants.

InfeXtious Therapeutic announces a Small Business Technology Transfer (STTR) grant award from the National Institute of Health (NIH).

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 20th Annual Global Healthcare Conference.